Explanatory Note
This Amendment No. 2 to statement on Schedule 13D (this “Amendment No. 2”) amends and supplements the Schedule 13D filed with the SEC on September 14, 2016 (as amended and supplemented by Amendment No. 1 to statement on Schedule 13D filed with the SEC on February 5, 2021 the “Prior Schedule 13D,” and as amended and supplemented by this Amendment No. 2, the “Schedule 13D”), and is being filed on behalf of the Reporting Person in respect of the Common Stock of the Issuer.
Except as amended and supplemented herein, the information set forth in the Prior Schedule 13D remains unchanged. Capitalized terms used but not defined in this Amendment No. 2 have the respective meanings set forth in the Prior Schedule 13D.
Item 2. | Identity and Background |
Item 2 of the Schedule 13D is hereby amended by incorporating herein by reference the information set forth on the updated Schedule A attached hereto.
Item 4. | Purpose of Transaction |
Item 4 of Schedule 13D is hereby amended and supplemented as follows:
Underwriting Agreement
On November 16, 2022, in connection with a registered public offering (the “Offering”) of Common Stock, the Issuer, the Reporting Person and the underwriters named therein (the “Underwriters”) entered into an underwriting agreement (the “Underwriting Agreement”) pursuant to which (i) the Reporting Person agreed to sell to the Underwriters, and the Underwriters agreed to purchase from the Reporting Person, subject to and upon the terms and conditions set forth therein, 1,000,000 shares of Common Stock, including 130,435 shares of Common Stock pursuant to the option granted to the Underwriters by the Reporting Person, in each case, at a price to the public of $11.50 per share, with net proceeds to the Reporting Person of $10.81 per share after deducting the commissions of the Underwriters and (ii) the Issuer agreed to sell to the Underwriters, and the Underwriters agreed to purchase from the Issuer, subject to and upon the terms and conditions set forth therein, 2,883,912 shares of Common Stock, including 376,162 shares of Common Stock pursuant to the option granted to the Underwriters by the Issuer, in each case, at a price to the public of $11.50 per share, with net proceeds to the Issuer of $10.81 per share. The Underwriters exercised their option granted by the Reporting Person and the Issuer on November 18, 2022, and the Offering was completed on November 21, 2022.
Lock-up Agreement
In connection with the Offering, on November 16, 2022, each of Min Woo Nam and Choon Yul Yoo delivered a lock-up agreement (each, a “Lock-Up Agreement,” and collectively, the “Lock-Up Agreements”) to Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the several Underwriters. Pursuant to the Lock-Up Agreements, each of Min Woo Nam and Choon Yul Yoo agreed during the period commencing on the date of the Lock-Up Agreements and ending 90 days after the date of the Underwriting Agreement not to (1) offer, sell, contract to sell, pledge, grant any option to purchase or otherwise dispose of any Common Stock, (2) exercise or seek to exercise any rights to cause the Issuer to register a disposition, (3) otherwise participate as a selling securityholder, or (4) engage in any transaction that is designed to dispose of the Common Stock.
The description of the Lock-Up Agreements in this Item 4 are qualified in their entirety by reference to the complete text of the form of Lock-Up Agreement which has been filed as Exhibit 6 hereto, and which is incorporated herein by reference in its entirety.
3